There are distinct neurobiological changes that occur in AD patients, including deposition of amyloid-beta (Aβ) plaques, neurofibrillary tangles of tau, neuroinflammation, and neuronal loss (Duyckaerts et al., 2009; Zhao, 2020). This evidence concerns the gene MAPT and Alzheimer disease.